Gunka I, Dostalik J, Martinek L, Gunkova P, Mazur M, Vavra P
Department of Surgery, University Hospital Ostrava, Czech Republic.
Acta Chir Belg. 2012 Mar-Apr;112(2):139-47. doi: 10.1080/00015458.2012.11680812.
Laparoscopic surgery for colon cancer has been proven safe, but controversy continues over implementation of laparoscopic technique for rectal cancer. The aim of this study was to compare the long-term outcomes of laparoscopically assisted and open surgery for nonmetastatic colorectal cancer.
From January 2001 to December 2006 all patients with nonmetastatic adenocarcinoma of the colon and rectum were considered for inclusion in this prospective non-randomised trial. The primary endpoint was overall survival, disease free survival and recurrence rate. Analysis was by intention to treat.
A total of 365 resections were performed for nonmetastatic adenocarcinoma of the colon and rectum during the study period. Of those resections, 220 were colonic and 145 were rectal. In the patients with colon cancer 119 (54.1%) were operated laparoscopically and 101 (45.9%) by open surgery, in the patients with rectal cancer 75 (51.7%) were treated by laparoscopy and 70 (48.3%) by open technique. No statistically significant difference was found between the laparoscopic and open group regarding 5-year overall survival (p = 0.17 for colon cancer, p = 0.60 for rectal cancer), 5-year disease free survival (p = 0.25 for colon cancer, p = 0.81 for rectal cancer) and overall recurrence (p = 0.78 for colon cancer, p = 0.79 for rectal cancer). With respect to the tumor stage, in rectal cancer the probability of 5-year disease free survival was significantly higher in the laparoscopic group in stage III (p = 0.03).
Laparoscopic surgery for colorectal cancer is an oncologically safe procedure that is associated with a survival and recurrence rate equal to open surgery.
腹腔镜手术治疗结肠癌已被证明是安全的,但对于直肠癌腹腔镜技术的应用仍存在争议。本研究的目的是比较腹腔镜辅助手术和开放手术治疗非转移性结直肠癌的长期疗效。
2001年1月至2006年12月,所有非转移性结肠和直肠癌腺癌患者均被纳入本前瞻性非随机试验。主要终点是总生存期、无病生存期和复发率。分析采用意向性治疗。
在研究期间,共对365例非转移性结肠和直肠癌腺癌进行了切除。其中,220例为结肠癌,145例为直肠癌。结肠癌患者中,119例(54.1%)接受了腹腔镜手术,101例(45.9%)接受了开放手术;直肠癌患者中,75例(51.7%)接受了腹腔镜治疗,70例(48.3%)接受了开放手术。腹腔镜组和开放组在5年总生存期(结肠癌p = 0.17,直肠癌p = 0.60)、5年无病生存期(结肠癌p = 0.25,直肠癌p = 0.81)和总复发率(结肠癌p = 0.78,直肠癌p = 0.79)方面均未发现统计学显著差异。在肿瘤分期方面,直肠癌患者中,腹腔镜组III期患者的5年无病生存概率显著更高(p = 0.03)。
结直肠癌的腹腔镜手术是一种肿瘤学上安全的手术,其生存率和复发率与开放手术相当。